78. Hypopituitarism Clinical trials / Disease details


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01209416
(ClinicalTrials.gov)
June 201224/9/2010The Effect of Pharmacological Antilipolysis on the Metabolic Effects of GhrelinThe Effect of Pharmacological Antilipolysis on the Metabolic Effects of GhrelinMetabolism;Insulin Resistance;HypopituitarismDrug: Acipimox;Drug: Ghrelin;Other: PlaceboUniversity of AarhusNULLCompleted18 Years65 YearsMale8N/ADenmark
2NCT00139945
(ClinicalTrials.gov)
October 200530/8/2005Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient PatientsEffects of Acute Ghrelin Infusion to Growth Hormone Deficient Adults: Growth Hormone and Cortisol InteractionHypopituitarismDrug: Human acylated ghrelinUniversity of AarhusNULLCompleted18 Years60 YearsBoth8N/ADenmark